Read the full post on Becker's ASC Review
Category: Becker’s ASC Review
Nobilis takes a Q2 hit, revenue down 13.5% after discontinuing lab testing ancillary: 8 things to know
Read the full post on Becker's ASC Review
4 recent ASC acquisitions & partnerships — July 2018
Read the full post on Becker's ASC Review
How ASCs can develop a stellar preauthorization process — 5 tips
Read the full post on Becker's ASC Review
Riverview Surgery Center under construction: 5 highlights
Read the full post on Becker's ASC Review
How 5 ASCs are preparing for outcomes-based reimbursement
Read the full post on Becker's ASC Review
5 most-read GI/endoscopy stories: July 26-August 1
Read the full post on Becker's ASC Review
Entyvio drives Takeda’s Q1 revenue growth: 6 things to know
Read the full post on Becker's ASC Review
5 takeaways from ACG’s new Crohn’s disease recommendations
Read the full post on Becker's ASC Review
University of Maryland Shore Regional Health proposes $75M medical campus with ASC — 4 insights
Read the full post on Becker's ASC Review
